INTRODUCTION
============

Lysosomal membrane permeabilization (LMP) has been implicated as an important trigger and amplifier of apoptosis and a crucial component of both developmental and stress-induced necrosis in diverse species of animals ([@B9]; [@B41]) and plants ([@B62]; [@B25]). In mammals, involution of the mammary gland upon cessation of nursing relies on LMP and necrosis rather than apoptosis ([@B31]). In the fruit fly *Drosophila melanogaster*, normal germ cell development relies on LMP ([@B44]; [@B67]). In the nematode *Caenorhabditis elegans*, neurons that have been stressed by hypoxia or hyperactive ion channels undergo LMP-dependent necrosis-like cell death in a process that involves cytosolic Ca^2+^, calpain proteases, the lysosomal membrane V-ATPase, and release of lysosomal cathepsin proteases and acids ([@B57], [@B56]). A similar calpain--cathepsin cascade triggers LMP in hippocampal CA1 neurons of primates during oxidative stress ([@B68]). In filamentous fungi, LMP may drive the vacuole-dependent programmed cell deaths that occur very rapidly upon mating of incompatible hyphal cells ([@B23]; [@B45]). LMP also occurs naturally in cells of the yeast *Saccharomyces cerevisiae* undergoing the developmental stage of sporulation, as part of the autolytic process that supplies essential nutrients to developing spores ([@B16]). Though the occurrence of LMP is apparently widespread among eukaryotes, the underlying molecular mechanisms that regulate these phenomena are poorly understood.

LMP may also be responsible for the fungicidal synergism of combining the azole class of fungistatic compounds (e.g., fluconazole, miconazole) commonly used to treat a wide array of fungal infections in humans with inhibitors of calcineurin (e.g., FK506, cyclosporin A; [@B19]; [@B54]; [@B33]). All the azoles target Erg11 (lanosterol desaturase), an essential enzyme in the endoplasmic reticulum (ER) that is required for cell proliferation but not required for cell survival. Azoles alone slow proliferation rates but do not kill fungal cells, but coadministration of azoles with calcineurin inhibitors causes dramatic loss of viability (i.e., a decline in colony-forming units). In most fungi, inhibitors of calcineurin alone or even knockout of calcineurin-encoding genes have little effect on growth rate in vitro, though virulence in vivo can be attenuated in some cases. The activation of calcineurin by Ca^2+^ and calmodulin therefore represents a protective response in many fungal species from the cidal effects of azole-class drugs.

The regulatory mechanism responsible for fungistat-induced and calcineurin-repressed LMP has been investigated most thoroughly in *S. cerevisiae*. Because this yeast is naturally resistant to most azole-class fungistats, the fungistatic compounds tunicamycin and dithiothreitol (DTT; inhibitors of Alg7 and Ero1 in the ER, which are required for protein N-glycosylation and protein disulfide bonding) were utilized instead and were shown to become fungicidal in the presence of calcineurin inhibitors (FK506 and cyclosporin A). Tunicamycin and DTT cause ER stress and activation of the UPR signaling pathway, but the Ire1 sensor/transducer of the UPR was not involved in either the activation of calcineurin or the suppression of cell death ([@B8]). Instead, calcineurin became activated through the activation of a stress-activated MAP kinase cascade ([@B7]), induction of K^+^ transporters ([@B52]; [@B53]), and activation of a high-affinity Ca^2+^ influx system that elevated cytosolic Ca^2+^ and activated calmodulin ([@B42]; [@B38]). In addition to calcineurin, the Ca^2+^/calmodulin-dependent protein kinase Cmk2 was found to weakly suppress cell death ([@B15]), similar to the cell death caused by high mating pheromones ([@B70]). A genome-wide screen for mutants that failed to die when exposed to ER stressors plus calcineurin inhibitors identified the V-ATPase, which directly pumps H^+^ and acidifies lysosomes and vacuoles, as necessary for LMP that precedes each cell death ([@B30]). The V-ATPase had been shown previously to promote LMP and necrosis-like deaths of degenerating neurons in *C. elegans* ([@B56]) and of involuting mammary glands ([@B3]). V-ATPase inhibitors blocked early stages of the response to tunicamycin, such as the fission of large vacuoles into many smaller ones, but were ineffective at blocking the later calcineurin-sensitive stages that lead to LMP and cell death ([@B30]). Though required for the early phase of LMP regulation, the V-ATPase is not likely a relevant target of calcineurin in these conditions. The substrates of calcineurin involved in LMP remain to be identified, as do the protein kinases responsible for their initial phosphorylation.

In this paper, we report the identification of the TORC1 protein kinase as a critical promoter of LMP and cell death in *S. cerevisiae* cells exposed to ER stressors and calcineurin inhibitors. TORC1 and its homologues in animals are multisubunit enzymes that associate peripherally with the limiting membranes of lysosomes and vacuoles and are the direct targets of the immunosuppressive drug rapamycin ([@B35]). TORC1 is well known as a master regulator of cell growth and proliferation, integrating a variety of nutrient and stress conditions and coordinating ribosome synthesis and function in translation. Mammalian TORC1 receives inputs from the V-ATPase, the RAG family of small GTPases, the Rheb family of small GTPases, and other regulators, which themselves relay information on cellular amino acid availability, energy resources, and stresses to TORC1 ([@B49]). Mammalian TORC1 has both prodeath and prosurvival activities in different cell types and circumstances ([@B64]). In *S. cerevisiae*, TORC1 activity depends partly on the RAG-family GTPases (Gtr1, Gtr2) and their membrane-tethering subunits (Ego1, Ego3), which together form the EGO complex that directly binds the vacuolar membrane and subunits of TORC1 ([@B35]). *S. cerevisiae* mutants lacking any subunit of the EGO complex have reduced TORC1 signaling and are hypersensitive to rapamycin and other inhibitors of TORC1 kinase activity such as caffeine ([@B46]; [@B65]). LMP, and subsequent death, of cells exposed to ER stressors and calcineurin inhibitors is shown below to be strongly delayed upon the loss of the EGO complex or the addition of rapamycin.

One of the few proteins found to promote LMP in mammalian cell lines is LAPF/phafin1 ([@B12]), which associates with lysosomal membranes through interactions with its conserved FYVE domain and a short C-terminal tail motif ([@B34]). Overexpression of LAPF/phafin1 additionally promoted autophagy ([@B32]), a process that is normally repressed by TORC1 signaling. An uncharacterized relative of LAPF/phafin1 in *S. cerevisiae*, termed Pib2, is shown in our study to utilize its FYVE domain and tail motif to promote LMP and death of stressed calcineurin-deficient cells through the stimulation of TORC1 signaling. These findings reveal a novel input to TORC1 signaling that involves PI(3)P interaction with FYVE domains of Pib2-family proteins. They also reveal a novel output of TORC1 signaling in *S. cerevisiae* and in *C. albicans* to promote LMP and nonapoptotic cell death responsible for conversion of fungistats into fungicides.

RESULTS
=======

Pib2, a FYVE-domain protein related to LAPF/phafin1, promotes LMP and cell death
--------------------------------------------------------------------------------

A recent study of more than 4800 viable gene-knockout mutants of *S. cerevisiae* revealed the multisubunit V-ATPase as necessary for LMP and the subsequent death of cells that were stressed with either tunicamycin or DTT in the presence of calcineurin inhibitors ([@B30]). Several additional vacuole-associated proteins were found to have roles in this process, and we focused on Pib2 first, because of its similarity to human LAPF/phafin1, which was previously shown to promote LMP and caspase-independent cell death in cell lines exposed to tumor necrosis factor α ([@B12]). Pib2 has not been studied extensively to date and was named originally for the presence of a putative PI(3)P-binding FYVE domain near the C-terminus ([@B50]). Clear orthologues of Pib2 were found encoded in the genomes of nearly all species of fungi using PSI-BLAST searches (see *Materials and Methods*). Alignment of Pib2 sequences from multiple fungal species revealed only two universally conserved motifs: the FYVE domain near the C-termini and a 13-amino-acid "tail motif" at the extreme C-termini, which were separated by a nonconserved spacer segment (see [Figure 1A](#F1){ref-type="fig"}). Though the N-terminal portions of these proteins were extremely variable and difficult to align, several other weakly conserved motifs (designated A to E motifs) could be discerned only among the yeasts or the ascomycetes (summarized in [Figure 1A](#F1){ref-type="fig"}). Of the 27 human proteins listed in the SMART database as containing FYVE domains, only LAPF/phafin1 contains a FYVE domain near the C-terminus and a conserved tail motif at the C-terminus. Multiple sequence alignments of LAPF/phafin1 orthologues from jawed vertebrates indicate similarity between its tail motif and that of the Pib2 family, except that it is extended by two amino acid residues ([Figure 1A](#F1){ref-type="fig"}). Vertebrates and most invertebrates also express a close paralogue of LAPF/phafin1 termed EAPF/phafin2, which appears to lack the entire tail motif but retains the FYVE domain as well as a strongly conserved pleckstrin homology (PH) domain at the N-terminus ([@B12]). In spite of the N-terminal differences, Pib2 and its orthologues in fungi seem to be the closest relatives of LAPF/phafin1 proteins in vertebrates.

![Domain architecture and subcellular localization of Pib2. (A) Schematic diagrams of Pib2 from *S. cerevisiae*, other budding yeasts (*C. albicans*, *Yarrowia lipolytica*), fission yeast (*Schizosaccharomyces pombe*), a mushroom (*Lichtheimia hyalospora*), plus EAPF/phafin1 and LAPF/phafin2 (*Homo sapiens*), indicating the approximate positions of partially conserved motifs (A--E) and the universally conserved FYVE domain and tail motif (T). Gray bars indicate segments of poor conservation. Sequence logos of tail motifs from Pib2- and LAPF/phafin1 proteins are shown. (B) Fluorescence micrographs of wild-type and *vps34∆* mutant strains of *S. cerevisiae* expressing GFP or GFP-Pib2 fusion protein (with and without the FYVE domain) after 30 min of staining with FM4-64 to reveal vacuolar and endosomal membranes.](4631fig1){#F1}

For testing whether Pib2 associates with PI(3)P in the membranes of endosomes and vacuoles, a green fluorescent protein (GFP)-Pib2 fusion protein was expressed at high levels from a methionine-repressible promoter in wild type and *vps34∆* mutants, which lack the sole enzyme capable of synthesizing PI(3)P ([@B48]). GFP-Pib2 clearly associated with the limiting membranes of large vacuoles and smaller endosome-like structures and was often enriched at sites of contact between these organelles ([Figure 1B](#F1){ref-type="fig"}). The dye FM4-64 was similarly localized but not enriched at these contact sites after endocytosis ([Figure 1B](#F1){ref-type="fig"}, bottom panels). GFP-Pib2 relocalized to the cytoplasm in *vps34∆* similar to GFP alone and a derivative of GFP-Pib2 that specifically lacked the FYVE domain ([Figure 1B](#F1){ref-type="fig"}). Therefore Pib2 localized to PI(3)P-rich intracellular membranes in *S. cerevisiae* similar to LAPF/phafin1-family proteins in animal cells.

The plasmid expressing GFP-Pib2 was able to fully restore high rates of cell death when introduced into *pib2∆* mutants in partially repressing conditions (100% methionine added), but this complementation declined unexpectedly as GFP-Pib2 became overexpressed by lowering methionine to 12.5% ([Figure 2A](#F2){ref-type="fig"}). In this experiment, cell death was measured 8 h after exposure of cells to tunicamycin plus FK506, an inhibitor of calcineurin, in standard synthetic complete (SC) medium. Interestingly, overexpression of GFP-Pib2 in wild-type cells also slowed the rate of cell death to levels approaching those of *pib2∆* cells ([Figure 2A](#F2){ref-type="fig"}). Therefore low levels of GFP-Pib2 complemented the *pib2∆* mutant, and high levels produced a dominant-negative effect in wild-type cells.

![Complementation and dominant-negative activities of GFP-Pib2 and truncated derivatives. (A) Wild-type and *pib2∆* mutant strains bearing plasmids that express GFP or GFP-Pib2 from a methionine-repressible promoter were grown in SC-leucine medium at different levels of methionine. Cells were then exposed to 2 μg/ml tunicamycin and 1 μg/ml FK506 for 8 h, stained with PI, and analyzed by flow cytometry. Bars indicate averages of three replicate cultures (± SD). (B) Wild-type (squares, solid curves) and *pib2∆* mutant (circles, broken curves) cultures were exposed to tunicamycin and FK506 for the indicated times, then stained with PI and analyzed by flow cytometry (black symbols) or stained with dihydro-DCFDA and analyzed microscopically (gray symbols) at the indicated times of incubation at 30°C. The average data from three replicate cultures were fitted to standard sigmoid equations (black curves) or the difference between two standard sigmoid equations (gray curves) using nonlinear regression as described in *Materials and Methods*. (C) A series of truncated GFP-Pib2 fusion proteins were expressed at low levels (100% met) in *pib2∆* cells or at high levels (12% met) in wild-type cells and then assayed for cell death (as in [Figure 2A](#F2){ref-type="fig"}), for hypersensitivity to caffeine (see *Materials and Methods*), and for subcellular localization (as in [Figure 1B](#F1){ref-type="fig"}). The degrees of complementation in the *pib2∆* mutant (compl.) and of dominant-negative activity in the wild-type strain (D.N.) were summarized on a scale of none (−) to full (++). Predominant localization to the cytoplasm (cyt.) or endosomal-vacuolar membranes (E-V) is indicated.](4631fig2){#F2}

The slower rates of cell death in *pib2∆* mutants and in strains overexpressing GFP-Pib2 could be attributable to either delayed onset of LMP or longer survival of post-LMP cells. To distinguish these possibilities, we stained cells with dihydro-DCFDA at different times after exposure to tunicamycin plus FK506. Dihydro-DCFDA specifically stains the cytoplasm of post-LMP cells that have not yet died ([@B30]), and therefore the frequency of positive-staining cells in the population rises, peaks, and declines as the individual cells undergo LMP and cell death. Cultures of wild-type cells exhibited such transient staining with dihydro-DCFDA, which was best fitted by a mathematical model in which the median cell remained alive for ∼1.1 h following LMP ([Figure 2B](#F2){ref-type="fig"}, solid curves). The *pib2∆* mutant culture exhibited slower cell death and lower frequencies of staining with dihydro-DCFDA than the wild-type culture ([Figure 2B](#F2){ref-type="fig"}, broken curves), which rules out the possibility that these cells underwent LMP at wild-type rates but survived longer in the post-LMP state. Overexpressed GFP-Pib2 in wild-type cells also exhibited lower staining with dihydro-DCFDA (unpublished data). Thus endogenous Pib2 promoted the onset of LMP, and overexpressed Pib2 delayed the onset of LMP, without any obvious effect on post-LMP survival times. This also suggests that endpoint measurements of cell death using propidium iodide (PI) serve as an excellent proxy for earlier LMP events that are transient and difficult to measure directly.

For determination of which conserved elements of Pib2 are important for its functions, several derivatives of the GFP-Pib2 fusion protein with N- and C-terminal truncations were expressed at low levels in *pib2∆* mutants (100% methionine) and at high levels in the wild-type parent strain (12% methionine). Then the levels of complementation and dominant-negative activity were assessed after exposure to tunicamycin plus FK506, as in [Figure 2A](#F2){ref-type="fig"}. Removal of the tail motif completely destroyed complementation in *pib2∆* mutants, and removal of N-terminal motifs progressively diminished complementation ([Figure 2C](#F2){ref-type="fig"}). Overexpression of the truncated derivatives in *pib2∆* mutants did not improve complementation (unpublished data), and potential dominant-negative effects could not be measured because of the low rate of cell death existing in *pib2∆* mutants. In wild-type cells, dominant-negative effects of overexpressed GFP-Pib2 truncations were clearly evident in all derivatives containing the poorly conserved N-terminal segment. Thus the N-terminal 49 amino acids of Pib2 were necessary and sufficient for most of the dominant-negative activity of overexpressed Pib2 in this test. Because Pib2 and all of the tested derivatives were unable to increase the rate of cell death in wild-type cells, Pib2 is not likely to function as a dose-dependent toxin that directly induces LMP and subsequent cell death. Instead, the dominant-negative activity of Pib2 and several of its derivatives is more consistent with a scaffold-like function wherein Pib2 could facilitate interactions between additional cellular factors when expressed at low levels and interfere with those interactions when overexpressed.

High-throughput screens have revealed that *pib2∆* mutants grow more poorly than wild-type strains in culture media supplemented with caffeine ([@B26]). We confirmed 3.6-fold caffeine hypersensitivity of *pib2∆* mutants (IC~50~ = 1.15 mM) relative to wild type (IC~50~ = 4.17 mM) in YPD medium (see *Materials and Methods*), and exploited this growth phenotype to reanalyze the functionalities of the truncated GFP-Pib2 derivatives described above. When expressed at low levels, only the full-length GFP-Pib2 protein fully reversed the caffeine hypersensitivity of the *pib2∆* mutants, and the N- and C-terminal truncated derivatives failed to complement caffeine hypersensitivity in a pattern that closely resembled the complementation results obtained from the cell death assays ([Figure 2C](#F2){ref-type="fig"}). Complementation by the truncated derivatives was not improved by overexpression, and indeed several truncations (two lacking just the tail motif and one lacking the N-terminal segment) strongly diminished caffeine resistance of the *pib2∆* mutants by an additional 2.1- to 4.6-fold (unpublished data). These same truncated derivatives also exhibited dominant-negative activity in the caffeine tolerance assays when overexpressed in wild-type cells, as did full-length GFP-Pib2 ([Figure 2C](#F2){ref-type="fig"}). Therefore motifs A through FYVE conferred dominant-negative activity in both the caffeine tolerance and the cell death assays, whereas the A motif alone conferred dominant-negative activity in just the cell death assay. Because human LAPF/phafin1 lacks motifs A through E, it was not expected to exhibit dominant-negative or complementation activities when expressed in *S. cerevisiae*, and indeed it was inert, though it still localized to vacuolar and endosomal membranes ([Figure 2C](#F2){ref-type="fig"}). The general concordance of the two complementation tests suggests that promotion of caffeine resistance and LMP are both manifestations of a single output of Pib2 that requires multiple conserved motifs, including the conserved tail motif.

Pib2 regulates TORC1 signaling independent of the EGO complex
-------------------------------------------------------------

No specific functions of Pib2 or any of its orthologues have been reported to date. To determine whether Pib2 functions are similar to any other proteins in *S. cerevisiae*, we downloaded two large data sets of chemical interaction profiles ([@B26]) and genetic interaction profiles ([@B13]) that were collected for thousands of gene-knockout mutants and performed hierarchical clustering of all the tested mutants. In the data set of chemical interactions, *pib2∆* mutants clustered tightly with several mutants that lack nonessential regulators or subunits of TORC1 (*gtr1∆*, *gtr2∆*, *ego1∆*, *ego3∆*, *lst4∆*, *lst7∆*, *tco89∆*, and *tor1∆*). All members of this group exhibit strong hypersensitivities to a cluster of chemicals that include rapamycin, caffeine, and related molecules, and consequently their profiles of chemical interactions are all strongly correlated with one another ([Figure 3A](#F3){ref-type="fig"}). In the data set of genetic interactions, *pib2∆* mutants again grouped with the TORC1-deficient mutants (*gtr1∆*, *gtr2∆*, *ego1∆*, *ego3∆*, *lst4∆*, and *lst7∆*), and all the mutants in this group correlated strongly with one another in their profiles of genetic interaction ([Figure 3B](#F3){ref-type="fig"}). These independent studies therefore implicate Pib2 as a potential regulator or subunit of TORC1 that had not been recognized previously.

![*pib2∆* mutants cluster with mutants deficient in TORC1 signaling. Data sets of chemical interactions ([@B26]) and genetic interactions ([@B13]) were subjected to hierarchical clustering (see *Materials and Methods*), and the clusters containing *pib2∆* mutants were visualized by calculating Pearson correlation coefficients between gene profiles (A and B). Raw scores for genetic interactions are also shown (C), and all tables were colored according to the indicated scale. The mutant lacking *NPR3*, a negative regulator of TORC1, exhibited anticorrelation with *pib2∆* and was manually moved into the cluster along with inverting the sign of correlation coefficient (B) and genetic interactions (C). The strain labeled *EGO3\** was labeled *ECM8* in the original studies, but this mutant failed to complement an *ego3∆* mutant and was renamed (see *Materials and Methods*). Mutant strains that could not be constructed or compared are indicated (X). Mutants for which synthetic lethality was confirmed by tetrad analysis are indicated (C).](4631fig3){#F3}

If Pib2 functions upstream of TORC1 as a positive regulator, the *pib2∆* knockout mutation may exhibit strong fitness defects when combined with knockout mutations in genes encoding other upstream regulators, such as the EGO complex (composed of Gtr1, Gtr2, Ego1, and Ego3, and stimulated by Lst4 and Lst7). Remarkably, double mutants carrying a *pib2∆* mutation and either a *gtr1∆*, *gtr2∆*, *ego1∆*, *ego3∆*, *lst4∆*, *lst7∆*, or *tco89∆* mutation each exhibited synthetic lethality or strong fitness defects, unlike the double mutants lacking two subunits of the EGO complex or its regulators (illustrated in [Figure 3C](#F3){ref-type="fig"}). Tetrad analysis of a sporulated *gtr1∆/+ pib2∆/+* double heterozygous diploid strain confirmed synthetic lethality of all *gtr1∆ pib2∆* double mutant ascospores except when they inherited a plasmid bearing a functional *GTR1* or *PIB2* gene (unpublished data). All of the viable *gtr1∆ pib2∆ \[GTR1 URA3\]* strains failed to grow in media containing 5'-FOA (5-fluoroorotic acid) that counterselects for the plasmid (see *Materials and Methods*), again confirming synthetic lethality of *gtr1∆ pib2∆* double mutants. Importantly, viability of the *gtr1∆ pib2∆* double mutant was fully restored by a single nucleotide substitution within the *TOR1* gene (*TOR1-I1954S*) that we recovered as a spontaneous mutation that reversed caffeine hypersensitivity of a *gtr1∆* mutant strain (see *Materials and Methods*). The *TOR1-I1954S* mutation also reversed caffeine hypersensitivity of *pib2∆* mutants and even increased caffeine resistance of wild-type cells (unpublished data), similar to a previously characterized *TOR1-I1954T* mutation that causes hyperactivation of TORC1 ([@B46]). The rescue of *gtr1∆ pib2∆* synthetic lethality by *TOR1-I1954S* in normal growth conditions strongly suggests that Pib2 and EGO complexes function independently and additively as upstream activators of TORC1 signaling, even in normal growth conditions.

Diminished rates of cell death were also observed in *gtr1∆* mutants ([Figure 4A](#F4){ref-type="fig"}) and in three other mutants lacking EGO complex subunits (unpublished data). Introduction of *TOR1-I1954S* into the *gtr1∆* mutant background and the *pib2∆* mutant background strongly increased the rates of cell death up to wild-type levels ([Figure 4A](#F4){ref-type="fig"}). Even the *gtr1∆ pib2∆ TOR1-I1954S* triple-mutant strain exhibited a wild-type rate of cell death ([Figure 4A](#F4){ref-type="fig"}, blue squares), showing that neither Pib2 nor the EGO complex were required for LMP and cell death as long as TORC1 signaling was sufficient. However, the hyperactive *TOR1-I1954S* mutation in an otherwise wild-type strain background did not accelerate the rate of cell death beyond the wild-type level ([Figure 4A](#F4){ref-type="fig"}, white vs. black circles). On the other hand, introduction of *npr2∆* mutation, which causes TORC1 hyperactivation by eliminating inhibitors of the EGO complex ([@B66]) and produces a genetic interaction profile that is anticorrelated with *gtr1∆* mutants ([Figure 3B](#F3){ref-type="fig"}), increased the rates of cell death in both *pib2∆* mutant and the wild-type backgrounds but not in the *gtr1∆* mutant background ([Figure 4B](#F4){ref-type="fig"}). Therefore the onset of LMP and the subsequent death of stressed cells correlated closely with overall levels of TORC1 signaling, which were diminished in *pib2∆* and *gtr1∆* and enhanced in *npr2∆* mutants.

![Pib2 stimulates TORC1 signaling independent of the Ragulator/EGO complex. Strains bearing *pib2∆*, *gtr1∆*, *gtr2∆*, or *ego1∆* knockout mutations (*∆* symbol sometimes omitted) and also bearing either the *TOR1-I1954S* point mutation (A), the *npr2∆* mutation (B), or plasmids expressing hyperactive (-h) and inactive (-i) variants of Gtr1 or Gtr2 (C) were grown in SC or SC-uracil medium, exposed to tunicamycin plus FK506 for 8 h, stained with PI, and analyzed by flow cytometry. The percentages of PI-positive (dead) cells were calculated from the average of three replicate cultures (± SD).](4631fig4){#F4}

The ability of an *npr2∆* mutation to increase death of *pib2∆* mutants but not *gtr1∆* mutants is consistent with the prevailing model, in which Npr2 functions as a negative regulator of the EGO complex ([@B66]) independent of Pib2. To further establish the independence of the EGO complex and Pib2, we tested whether hyperactive variants of Gtr1 and Gtr2 ([@B21]) would increase death of *pib2∆* mutants when expressed from plasmids ([Figure 4C](#F4){ref-type="fig"}). Hyperactive Gtr1-h significantly increased the rate of death in *pib2∆* and *gtr1∆* mutants but not in *gtr2∆* or *ego1∆* mutants that lack other components of the EGO complex. Hyperactive Gtr2-h increased the rate of death in *gtr2∆* mutants but not in *gtr1∆* or *ego1∆* or *pib2∆* mutants, suggesting it was less efficient in activating the EGO complex than hyperactive Gtr1-h. Inactive Gtr2-i did not complement the *gtr2∆* mutant and exhibited dominant-negative effects on the rate of cell death in *pib2∆* and especially in *npr2∆ pib2∆* double mutants, which lack the Pib2 input into TORC1 and therefore rely more heavily on the EGO complex ([Figure 4C](#F4){ref-type="fig"}). Thus the EGO complex and its upstream regulators all interacted as expected from earlier studies and regulated cell death through TORC1 independent of Pib2.

To determine whether Pib2 affects basal signaling through TORC1, we studied the phosphorylation status of several TORC1 effectors by Western blot analysis of whole-cell lysates. Phosphorylation of ribosomal protein S6 (Rps6) dramatically declines upon addition of rapamycin to growing cells ([@B24]). Using antibodies that specifically recognize phospho-Rps6, we confirmed that rapamycin causes a large and rapid decline of Rps6 phosphorylation in growing wild-type cells relative to loading control (Pgk1; [Figure 5A](#F5){ref-type="fig"}). However, the *gtr1∆* and *pib2∆* mutants exhibited little or no decrease in phospho-Rps6 levels during exponential growth ([Figure 5A](#F5){ref-type="fig"}). Introduction of the *npr2∆* mutation into these strains did not detectably increase phospho-Rps6 levels, but did diminish the effects of rapamycin when Gtr1 and Pib2 were functioning, and not in the *gtr1∆* and *pib2∆* mutant strains. On the other hand, the Par32 phosphoprotein, which undergoes large shifts in mobility on SDS--PAGE in response to rapamycin ([@B27]), shifted significantly in *gtr1∆* and *pib2∆* mutants relative to wild type ([Figure 5B](#F5){ref-type="fig"}), suggesting partial deficiency of TORC1 signaling in both of the mutants. The simplest hypothesis consistent with all these findings is that Pib2 and the EGO complex independently stimulate basal TORC1-dependent signaling in growing *S. cerevisiae* cells.

![Altered phosphorylation of TORC1-sensitive proteins in *pib2∆* mutants. (A) Wild type, *pib2∆*, and *gtr1∆* mutants with and without additional *npr2∆* knockout mutation were grown to log phase in SC medium and exposed to 200 ng/ml rapamycin for 1 h. Proteins were extracted, separated by SDS--PAGE, and analyzed by Western blotting using antibodies specific for phospo-Rps6 and Pgk1 as a loading control. The same strains bearing a Par32-HA expression plasmid were grown in SC-uracil medium (B) or SC-uracil minus all other nonessential amino acids to diminish basal TORC1 signaling (C), exposed to rapamycin as above, and analyzed by Western blotting using anti-HA monoclonal antibodies.](4631fig5){#F5}

TORC1-sensitive processes respond to ER stress
----------------------------------------------

Does TORC1 signaling increase in response to ER stresses or calcineurin signaling? To answer this question, we monitored the TORC1-sensitive changes in phosphorylation of Rps6 and Par32 at several different times following exposure to tunicamycin or tunicamycin plus FK506. Within the first 2--3 h of exposure to either drug, the phosphorylation status of both proteins was not significantly altered in either wild-type cells or in *pib2∆* cells, though the mutant cells exhibited reduced TORC1 activity ([Figure 6](#F6){ref-type="fig"}), as observed earlier. Even an *ire1∆* mutant, which lacks a functional UPR signaling pathway and is hypersensitive to tunicamycin, exhibited no apparent change in the TORC1-sensitive phosphoproteins within the first 2 h ([Figure 6](#F6){ref-type="fig"}). Thus TORC1 signaling appeared unresponsive to ER stress and calcineurin signaling within this time frame.

![Tunicamycin and FK506 have little impact on TORC1 signaling. Wild-type, *pib2∆* mutant, and *ire1∆* mutant strains were grown to log phase in SC medium, exposed to tunicamycin (Tm), rapamycin (Rap), and calcineurin inhibitor (FK506) as indicated. Aliquots of each culture were removed before or 0.25, 0.5, 1, 2, or 4 h after drug addition and extracted rapidly, and total cell protein was analyzed by SDS--PAGE and Western blotting using antibodies that recognize phosopho-Rps6, total Rps6, Pib2, Pgk1, and the HA epitope of Par32-HA, which was expressed from plasmid pMS034.](4631fig6){#F6}

Interestingly, total Rps6 protein levels declined dramatically in all three strains after 3--4 h of exposure to tunicamycin ([Figure 6](#F6){ref-type="fig"}). Such a decline was not observed for Pgk1, which served as a control for gel loading. In spite of this decline in total Rps6 abundance, the residual Rps6 remaining at 4 h was completely shifted to a faster-migrating species that probably represented the dephosphorylated form, as it was not detected by anti phospho-Rps6 antibodies. In the presence of FK506, the decline in total Rps6 was unaltered, but the residual protein in wild-type and *ire1∆* mutant cells was found in both phosphorylated and dephosphorylated forms. No residual phospho-Rps6 was detected in the *pib2∆* mutant. These findings may indicate that a decline in TORC1 signaling occurs after several hours of exposure to tunicamycin and that calcineurin signaling may hasten the decline. However, this conclusion was not substantiated when Par32 was used as the reporter of TORC1 signaling ([Figure 6](#F6){ref-type="fig"}).

Finally, we examined Pib2 mobility under these same conditions to determine whether this protein responds to ER stress, calcineurin, or TORC1. In both wild type and *ire1∆* mutants, Pib2 shifted from a slightly slower and more diffuse band to a faster and sharper band after 1 h of exposure to rapamycin ([Figure 6](#F6){ref-type="fig"}, right lanes), suggesting that phosphorylation of Pib2 is also responsive to TORC1, as observed previously ([@B37]). Similar mobility changes were observed during the first 2 h of exposure to tunicamycin or tunicamycin plus FK506. Thus Pib2 appeared to become modified in response to ER stress, and the modification was potentially a result of diminished TORC1 signaling. In any case, we obtained no evidence for increased TORC1 signaling at any time during the response to ER stress.

Vacuole fragmentation during ER stress requires TORC1
-----------------------------------------------------

ER stress induces slow vacuole fragmentation without leakage of contents, which arises as a consequence of diminished vacuole--vacuole fusion events in the face of ongoing fission events ([@B4]). Interestingly, GFP-Pib2 became concentrated near the sites of vacuole--vacuole contact as indicated by staining with FM4-64 ([Figure 7A](#F7){ref-type="fig"}). For investigation of the potential roles of Pib2 and TORC1 signaling in this process, FM4-64--stained cells were exposed to tunicamycin in the presence and absence of rapamycin and then monitored over time. While rapamycin greatly slowed the rate of vacuole fragmentation in wild-type cells ([Figure 7B](#F7){ref-type="fig"}, left), the *pib2∆* and *gtr1∆* mutants were indistinguishable from wild-type cells in the response to tunicamycin (right). These findings suggest that low levels of TORC1 signaling may be sufficient for normal vacuole fission in these conditions. A potent inhibitor of the V-ATPase concanamycin C also blocked vacuole fragmentation in wild-type cells during ER stress ([@B4]). If the V-ATPase were required only for TORC1 activation, strains with hyperactive TORC1 signaling would still undergo vacuole fragmentation in the presence of V-ATPase inhibitor. In contrast to this hypothesis, concanamycin C efficiently inhibited vacuole fragmentation and cell death in both *TOR1-I1974S* and *npr2∆* mutant strains (unpublished data). Therefore the V-ATPase and TORC1 both played important and potentially independent roles in the vacuole fragmentation that occurs in response to ER stress.

![Vacuole fragmentation during ER stress depends on TORC1 signaling but not Pib2 or Gtr1. (A) Wild-type cells expressing GFP-Pib2 and prestained with FM4-64 were exposed to tunicamycin or vehicle control for 2 h and imaged by fluorescence microscopy. (B) Wild-type, *pib2∆* mutant, and *gtr1∆* mutant strains were prestained with FM4-64, exposed to tunicamycin for 2 h (right) or up to 2 h (left), and imaged by fluorescence microscopy, and then 200 cells were scored as having either 1 or 2 (large) vacuoles or \>3 vacuoles. Data points and bars represent the average of three replicate cultures (± SD).](4631fig7){#F7}

TORC1 acts at early stages in the pathway leading to LMP and cell death
-----------------------------------------------------------------------

For determination of whether TORC1 activity promotes steps in addition to vacuole fragmentation that lead to LMP and cell death, rapamycin was added together with a calcineurin inhibitor at different times after exposure of wild-type cells to tunicamycin. To avoid possible interference between rapamycin and FK506, which both utilize the same FKBP-12 receptor protein to mediate their inhibition of their targets, we used cyclosporine A as the inhibitor of calcineurin. Interestingly, rapamycin strongly delayed cell death when added at the same time as tunicamycin but completely failed to slow cell death when added 2 h after tunicamycin exposure, when vacuoles had already fragmented in nearly all cells ([Figure 8A](#F8){ref-type="fig"}). This finding suggests that TORC1 activity, like V-ATPase activity, performs its prodeath functions in the early stages of the response to ER stress and is not required for the calcineurin-sensitive stages that occur later and lead to LMP and cell death. As shown earlier, TORC1 loses activity after several hours of tunicamycin exposure ([Figure 6](#F6){ref-type="fig"}).

![TORC1 signaling promotes fungicidal synergism in *S. cerevisiae* and *C. albicans*. (A) The wild-type strain of *S. cerevisiae* was grown to log phase in SC medium, exposed to tunicamycin beginning at 0 h, and then either calcineurin inhibitor (CsA) or calcineurin plus TORC1 inhibitors (CsA+Rap) were added 0, 2, or 4 h later (black, red, or blue lines). At the indicated times, the cultures were sampled and stained with PI, and the fraction of dead cells was determined by flow cytometry. The average (± SD) of three replicate cultures is shown. (B) Wild type, *cnb1∆* mutant, *cmk2∆* mutant, and *cmk2∆ cnb1∆* double mutants of *C. albicans* were grown to log phase in SC medium; exposed to fluconazole (+Flu), rapamycin (+Rap), or both (+Flu+Rap) for 8 h; and then stained with PI and analyzed by flow cytometry for the fraction of dead cells in the population. Bars represent the averages (± SD) of three replicate cultures.](4631fig8){#F8}

TORC1 promotes fungicidal actions of fluconazole in calcineurin-deficient *C. albicans*
---------------------------------------------------------------------------------------

In many pathogenic yeasts and fungi, calcineurin inhibitors convert fungistats such as fluconazole into fungicides, possibly by inducing VMP. To test whether TORC1 promotes death in these circumstances, we exposed cultures of calcineurin-deficient (*cnb1∆* homozygous mutant) *C. albicans* to fluconazole in the presence and absence of rapamycin and analyzed them for cell death using PI stain. Fluconazole strongly killed the *cnb1∆* mutants in comparison with the isogenic wild-type parent strain, and rapamycin completely blocked this effect ([Figure 8B](#F8){ref-type="fig"}). Similar results were obtained using tunicamycin as the stressor instead of fluconazole (unpublished data). In *S. cerevisiae* cells, a Ca^2+^/calmodulin-dependent protein kinase (Cmk2) plays a secondary role in suppression of LMP and cell death that can be visualized only in calcineurin-deficient cells ([@B15]). A secondary role of Cmk2 in suppression of cell death was also observed in *C. albicans* cells exposed to mating pheromones ([@B1]). Similar to *S. cerevisiae* strains, the *cmk2∆* mutant behaved like wild type, and the *cmk2∆ cnb1∆* double mutant exhibited slightly higher levels of cell death than the *cnb1∆* single mutant after exposure to fluconazole, and those cell deaths were fully blocked by rapamycin ([Figure 8B](#F8){ref-type="fig"}). Therefore TORC1 played important prodeath roles in calcineurin-deficient *C. albicans* and *S. cerevisiae* cells alike when the cells were stressed by either synthetic (e.g., fluconazole) or natural (e.g., tunicamycin) fungistats.

DISCUSSION
==========

The molecular mechanism by which calcineurin prevents death of fungal cells that have been exposed to fungistatic drugs is not understood, but it seems to be conserved across diverse fungal phyla ([@B19]; [@B54]; [@B33]). Early studies in *S. cerevisiae* ruled out the known targets of calcineurin as strong regulators of cell death ([@B15]), and later a genome-wide screen revealed the V-ATPase and leakage of luminal material from vacuoles into the cytoplasm as critical components of the pathway leading to cell death ([@B30]). Calcineurin also promotes survival of *S. cerevisiae* cells that have been stressed with aggregated forms of human α-synuclein, which is a primary determinant of neurodegeneration in Parkinson\'s disease ([@B11]). In other models of neurodegeneration and in mammary gland involution, the V-ATPase and LMP have been implicated ([@B56]; [@B3]). These findings hint at possible conservation between fungi and animals of a mechanism that controls and regulates LMP. In this study, we extended this comparison by focusing on a protein (Pib2) that is related to a protein (LAPF/phafin1) implicated as an inducer of LMP in human L929 cells ([@B12]). We show that Pib2 increases TORC1 signaling and that full TORC1 signaling is required for LMP and cell death in both *S. cerevisiae* and *C. albicans* caused by the combination of fungistats and calcineurin inhibitors.

Lysosomes and vacuoles naturally undergo fission and fusion reactions without leakage of luminal content ([@B51]). In response to tunicamycin and other fungistats, vacuole fusion appears to be selectively inhibited, and due to ongoing fission, vacuoles become highly fragmented in appearance within the first 2 h ([@B30]). This fragmented state persists for several hours with little cell death in the population. Though calcineurin inhibitors did not alter kinetics of vacuole fragmentation, the fragmented vacuoles appeared to fuse again about the same time as luminal molecules were released into the cytoplasm ([@B30]). Pib2 associated with the limiting membranes of vacuoles and endosomes in unstressed cells and concentrated at the sites of vacuole--vacuole contact in the stressed cells, in a manner that depended on its FYVE domain and PI(3)P synthesis in these membranes. Therefore Pib2 is well positioned to mediate LMP, membrane fusion, or other phenomena that could lead to death of calcineurin-deficient cells. However, overexpression of Pib2 or its truncated derivatives in wild-type cells did not accelerate the rate of cell death in any circumstances tested and, upon exposure to tunicamycin plus FK506, interfered with the process in a dominant-negative manner that is more typical of scaffolds than of a pore-forming protein such as Bax.

The data presented here show that Pib2 naturally stimulates TORC1 signaling via a pathway that is independent of the EGO complex and its upstream regulators. Though *pib2∆* mutants exhibit chemical and genetic interaction profiles that are correlated with *gtr1∆* and other mutants deficient in the EGO complex, Pib2 had not been associated previously with TORC1 signaling. Synthetic lethality between *pib2∆* and *gtr1∆* mutations may have obscured the association. Like mutants deficient in the EGO complex, *pib2∆* mutants are viable and exhibit phenotypes indicative of diminished TORC1 signaling (hypersensitivity to rapamycin and caffeine, hypo-phosphorylation of Rps6, hyperphosphorylation of Par32, and diminished rates of cell death), at least some of which can be reversed by a hyperactivating I1954S substitution in Tor1 that is very similar to a previously characterized hyperactivating I1954T substitution ([@B46]). Thus Pib2 and EGO complexes seem to activate TORC1 independently and additively, with full TORC1 activity being necessary for LMP and cell death in the conditions studied here. A second EGO complex--independent pathway of TORC1 activation was recently identified as responsive to glutamine feeding ([@B55]). It will be interesting to determine whether that regulatory pathway involves Pib2 or some other factor, whether other proteins function with Pib2 in the regulation of TORC1, and whether Pib2 communicates the concentration of some nutrient or metabolite to TORC1.

This simple model becomes more complicated, however, when additional findings are also considered. First, Pib2 interacted with all four subunits of the EGO complex in the protein-fragment complementation assay (PCA) format of a yeast two-hybrid screen ([@B58]). We independently confirmed interactions between Pib2 and Gtr1, Ego1, and the Kog1 subunit of TORC1 using a split-ubiquitin yeast two-hybrid system ([@B6]; unpublished data), but we could not confirm physical interactions in coimmunoprecipitation experiments. While Pib2 stimulated TORC1 signaling, it may also inhibit TORC1 signaling by inhibiting functions of the EGO complex. This hypothesis could explain why truncated nonstimulatory derivatives of Pib2 exhibited strong caffeine hypersensitivity when overexpressed in *pib2∆* and wild-type cells. Second, phosphorylation of Pib2 changed in response to rapamycin ([@B37]; [Figure 6](#F6){ref-type="fig"}), suggesting that Pib2 may be an effector or feedback regulator of TORC1. The nonessential Tco89 regulatory subunit of TORC1 also undergoes rapid changes in phosphorylation in response to rapamycin ([@B27]; [@B43]) that are of unknown significance. More research is necessary to fully understand the complete set of interactions between Pib2 and TORC1. The mechanism by which the EGO complex regulates TORC1 will be easier to determine in the *pib2∆* mutant background, which lacks the alternative and potentially confounding source of inputs into TORC1.

Recently phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) in vacuolar membranes was found to be important for activation of TORC1 signaling in *S. cerevisiae* through interactions with the essential subunit Kog1 and certain effectors such as Sch9 ([@B28]). Raptor, the mammalian homologue of Kog1, also bound PI(3,5)P2 ([@B10]). Because PI(3)P, the immediate precursor of PI(3,5)P2, and the FYVE domain of Pib2 were necessary for recruitment of the protein to the vacuolar membrane, it is tempting to speculate that TORC1 signaling also responds to PI(3)P. Though *vps34∆* mutants exhibit hypersensitivity to rapamycin and caffeine ([@B5]; [@B10]), this mutant lacks both PI(3)P and PI(3,5)P2. In *S. cerevisiae*, two distinct PI(3) kinases are thought to exist that share several subunits (Vps34, Vps15, Atg6) and also contain a unique subunit for complex I (Atg14) and for complex II (Vps38), which promote autophagy and vesicle trafficking, respectively ([@B29]). A *vps38∆* mutant exhibited a 67% decrease in PI(3)P accumulation and weak hypersensitivity to rapamycin ([@B10]), but these mutants died at wild-type rates when exposed to tunicamycin plus FK506 ([@B30]). Interestingly, *atg14∆* mutants were resistant to rapamycin and exhibited diminished rates of cell death ([@B30]), potentially exposing a role for autophagy in the regulation of LMP. However, *atg6∆* and many other autophagy-deficient mutants of *S. cerevisiae* exhibited near wild-type rates of cell death ([@B30]). Thus the PI(3)P synthesized by complex I may be more important for promoting cell death, while the PI(3)P synthesized by complex II may be more important for TORC1 activation in yeasts. The situation may be even more complicated in mammalian cells, in which TORC1 phosphorylates Atg14 and inhibits PI(3)P synthesis by complex I ([@B69]).

Currently there is no direct evidence for LAPF/phafin1 regulation of TORC1 in animals. LAPF/phafin1 requires its FYVE domain for localization to lysosomal and endosomal limiting membranes, but it differs from Pib2 in that lysosomal localization also required the tail motif ([@B32]). In HEK293T cells, overexpressed LAPF/phafin1 caused enlargement of endocytic vesicles and enhanced endocytosis and autophagy ([@B32]). Though these effects were not observed upon overexpression of EAPF/phafin2, which lacks the tail motif, overexpression of the tail-less homologue in *Drosophila* (termed Rush) produced similar effects and appeared to modulate endocytosis through interactions with regulators of Rab7 GTPase activity ([@B20]). These effects on endocytosis may be unique properties of the phafins in animals, as these proteins all contain well-conserved pleckstrin homology (PH) domains at their N-termini that are not present in the fungal homologues of Pib2. Likewise, there is no direct evidence for a role of Pib2 in endocytosis outside of its role in regulating TORC1 signaling. Therefore the fungal and animal families of proteins containing FYVE domains and tail motifs may not be descended from a common ancestor, or they may function divergently in the fungal and animal kingdoms.

How does TORC1 promote LMP and death of stressed cells lacking calcineurin function, and thereby contribute to cidal effects of fungistats? TORC1 signaling stimulates expression of ribosomes and the initiation stages of translation, the expression and trafficking of amino acid permeases, the down-regulation of autophagy, and the modulation of several metabolic and regulatory cascades ([@B35]). At present, it is unclear how such diverse outputs could contribute to LMP and cell death in these circumstances. If the rapamycin-induced up-regulation of autophagy were somehow protective, autophagy-deficient mutants would be expected to exhibit higher rates of cell death than wild type. Of the 30 different autophagy-deficient (*atg*) mutants tested in our original genome-wide screen, only the *atg15∆* mutants exhibited elevated rates of cell death. The *atg15∆* mutants lack a lipase in the lumen of vacuoles that is responsible for degrading luminal vesicles and is not directly involved in autophagic uptake of cellular material into vacuoles ([@B18]; [@B59]). We report here another role of TORC1 signaling during the response to stress: the stimulation of vacuole fission or inhibition of vacuole fusion. Though *gtr1∆* and *pib2∆* mutants exhibited roughly wild-type rates of vacuole fragmentation during exposure to tunicamycin, rapamycin strongly inhibited vacuole fragmentation in stressed cells. Residual TORC1 signaling in *gtr1∆* and *pib2∆* cells was therefore sufficient to promote vacuole fragmentation but not for eventual cell death. TORC1 signaling has previously been shown to promote vacuole fission in vitro and in live *S. cerevisiae* cells responding to salt stress ([@B40]). Using several readouts of TORC1 signaling, we found no evidence that tunicamycin stimulates TORC1 signaling and evidence that TORC1 signaling slowly declines to undetectable levels after about 2 h of stress, and even faster in *gtr1∆* and *pib2∆* mutants. The ability of rapamycin to block cell death also declined to undetectable levels by 2 h of stress ([Figure 8](#F8){ref-type="fig"}). All of these findings together suggest that TORC1 signaling is necessary only in the early stages of the response to stress, priming the cells for later calcineurin-sensitive stages that lead to vacuole fusion, LMP, and cell death.

While TORC1 activity promoted LMP and cell death in stressed yeasts, it had the opposite effect on necrosis-like death of degenerating neurons in the nematode *C. elegans*, potentially through the down-regulation of autophagy ([@B61]). This model of neurodegeneration is induced by hyperactive ion channels that are expressed in the dying neurons and has been shown previously to depend on elevation of cytosolic Ca^2+^, calpain activation, V-ATPase activity, and release of lysosomal cathepsins into the cytoplasm, and therefore is a well-established model of LMP in animals ([@B9]; [@B68]; [@B41]). On the other hand, TORC1 can also promote cell death in other models of neurodegeneration, usually through induction of apoptosis ([@B64]). LMP regulatory mechanisms in animals are thus complicated by the variable types of cellular stresses, the diversity of cell types, and the emerging cross-talk between LMP, autophagy, and apoptosis. More research on LMP control mechanisms in fungi and animals may provide insights into controlling fungal infections and neurodegenerative disease.

MATERIALS AND METHODS
=====================

Yeast strains, culture media, and reagents
------------------------------------------

The yeast strains used in this study were generated from the wild-type parent BY4741 and BY4742 strain backgrounds using standard gene-knockout procedures ([@B36]) and/or crosses (see [Table 1](#T1){ref-type="table"}). The primers used for gene knockouts are available upon request, and all knockouts were confirmed by PCR analysis using flanking oligonucleotides. Yeast strains were cultured in rich yeast--peptone--dextrose (YPD) medium, SC medium containing all 20 amino acids plus adenine and uracil, or SC medium lacking a nutrient for plasmid selection. For some experiments, the concentration of methionine was varied from 100% (100 μg/ml) to 12%.

###### 

Yeast strains and plasmids used in this study. Continued

  Strain name                                               Genotype                                   Source       Parent          F primera         R primera
  --------------------------------------------------------- ------------------------------------------ ------------ --------------- ----------------- -----------------
  *S. cerevisiae* strains                                                                                                                             
  BY4741                                                    *MATa his3∆1 leu2∆2 met15∆0 ura3∆0*        [@B22]                                         
  BY4742                                                    *MATα his3∆1 leu2∆2 lys2∆0 ura3∆0*         [@B22]                                         
  K1259                                                     *MATa ire1::G418*                          [@B8]        BY4741                            
  AK018                                                     *MATa pib2::NAT*                           This study   BY4741          Pib2 KO F11       Pib2 KO R11
  AK025                                                     *MATa npr2::HIS3*                          This study   BY4741          Npr2 KO F1        Npr2 KO R0
  AK060                                                     *MATa gtr1::NAT*                           This study   BY4741          Gtr1 KO F11       Gtr1 KO R11
  AK061                                                     *MATa gtr2::NAT*                           This study   BY4741          Gtr2 KO F11       Gtr2 KO R11
  AK062                                                     *MATa ego1::NAT*                           This study   BY4741          Ego1 KO F11       Ego1 KO R11
  AK063                                                     *MATa ego3::NAT*                           This study   BY4741          Ego3 KO F11       Ego3 KO R11
  AK109                                                     *MATa iml1::HIS3*                          This study   BY4741          Iml1 KO F11       Iml1 KO R11
  AK069                                                     *MATa npr2::HIS3 gtr1::NAT*                This study   AK060           Npr2 KO F1        Npr2 KO R0
  AK070                                                     *MATa npr2::HIS3 gtr2::NAT*                This study   AK061           Npr2 KO F1        Npr2 KO R0
  AK071                                                     *MATa iml1::HIS3 gtr1::NAT*                This study   AK060           Iml1 KO F11       Iml1 KO R11
  AK072                                                     *MATa iml1::HIS3 gtr2::NAT*                This study   AK061           Iml1 KO F11       Iml1 KO R11
  AK105                                                     *MATα pib2::G418*                          This study   BY4742          Pib2 KO F11       Pib2 KO R11
  AK101                                                     *MATα gtr1::NAT*                           This Study   BY4742          Gtr1 KO F11       Gtr1 KO R11
  AK060-b03                                                 *MATa tor1-I1954S gtr1::NAT*               This study   AK060                             
  AK102                                                     *MATα tor1-I1954S gtr1::NAT*               This study   AK105/060-b03                     
  AK104                                                     *MATα tor1-I1954S*                         This study   AK105/060-b03                     
  AK106                                                     *MATα tor1-I1954S pib2::G418*              This study   AK105/060-b03                     
  AK107                                                     *MATα tor1-I1954S gtr1::NAT pib2::G418*    This study   AK105/060-b03                     
  *C. albicans* strains                                                                                                                               
  RBY1182                                                   a/α *leu2/leu2 his1/his1*                  [@B1]                                          
  DSY797                                                    *cnb1::HIS1/cnb1::LEU2*                    [@B1]                                          
  KAY483                                                    *cnb1::HIS1/cnb1::LEU2 cmk2∆/cmk2::SAT1*   [@B1]                                          
  KAY481                                                    *cmk2::SAT1/cmk2::SAT1*                    [@B1]                                          
  Plasmids                                                                                                                                            
  pSM214                                                    \[MET\]-GFP AmpR *CEN LEU2*                [@B39]       p415MET25                         
  pAK009                                                    \[MET\]-GFP-Pib2                           This study   pSM214          Pib2-F-SpeI       Pib2-Stop-XhoI
  pAK010                                                    \[MET\]-GFP-Pib2(1-49)                     This study   pSM214          Pib2-F-SpeI       Pib2+147R
  pAK011                                                    \[MET\]-GFP-Pib2(1-101)                    This study   pSM214          Pib2-F-SpeI       Pib2+303R
  pAK012                                                    \[MET\]-GFP-Pib2(1-162)                    This study   pSM214          Pib2-F-SpeI       PIB2+488R
  pAK013                                                    \[MET\]-GFP-Pib2(1-312)                    This study   pSM214          Pib2-F-SpeI       PIB2+938R
  pAK014                                                    \[MET\]-GFP-Pib2(1-360)                    This study   pSM214          Pib2-F-SpeI       Pib2 +1080R
  pAK015                                                    \[MET\]-GFP-Pib2(1-428)                    This study   pSM214          Pib2-F-SpeI       PIB2+1284R
  pAK016                                                    \[MET\]-GFP-Pib2(1-555)                    This study   pSM214          Pib2-F-SpeI       Pib2 +1665R
  pAK017                                                    \[MET\]-GFP-Pib2(1-620)                    This study   pSM214          Pib2-F-SpeI       Pib2 +1860R
  pAK018                                                    \[MET\]-GFP-Pib2(50-635)                   This study   pSM214          Pib2+148F         Pib2-Stop-XhoI
  pAK019                                                    \[MET\]-GFP-Pib2(102-635)                  This study   pSM214          Pib2+304F         Pib2-Stop-XhoI
  TABLE 1: Yeast strains and plasmids used in this study.                                                                                             
  pAK020                                                    \[MET\]-GFP-Pib2(165-635)                  This study   pSM214          PIB2+493F         Pib2-Stop-XhoI
  pAK021                                                    \[MET\]-GFP-Pib2(304-635)                  This study   pSM214          PIB2+910F         Pib2-Stop-XhoI
  pAK022                                                    \[MET\]-GFP-Pib2(440-635)                  This study   pSM214          PIB2+1318F        Pib2-Stop-XhoI
  pAK023                                                    \[MET\]-GFP-Pib2(-∆FYVE)                   This study   pSM214          Pib2 1582-FYVEF   Pib2 1326-FYVER
  pCK294                                                    Gtr1-i (-S20L) CEN URA3                    [@B21]                                         
  pCK295                                                    Gtr1-h (-Q65L) CEN URA3                    [@B21]                                         
  pCK296                                                    Gtr2-h (-S23L) CEN URA3                    [@B21]                                         
  pCK297                                                    Gtr2-i (-Q66L) CEN URA3                    [@B21]                                         
  pMS034                                                    Par32-HA CEN URA3                          [@B27]                                         

^a^Sequences of forward and reverse PCR primers are available upon request.

*S. cerevisiae* strains bearing TORC1 hyperactivating mutations were obtained as follows. First, independent colonies of the caffeine-sensitive *gtr1∆* mutant strain were grown in YPD medium and plated on YPD agar medium containing 8 mM caffeine. One caffeine-resistant colony (suppressor) was picked from each parent colony, purified, and then tested for restoration of wild-type rates of cell death when exposed to tunicamycin plus FK506 in SC medium. Of the 29 suppressors (80% of total) that passed this test, four were found to confer caffeine resistance in a dominant manner (in heterozygous diploids), and the remainder were less dominant or recessive. One dominant suppressor and four recessive suppressors were subjected to whole-genome resequencing at the Next Generation Sequencing Center (Johns Hopkins Medical Institutions), and in each case, only one single nucleotide substitution was found, four of which altered the sequence of *TOR1* (resulting in Tor1-I1954S \[dominant\], -A1927E, -A1957V, -L2271V), and one of which altered the sequence of *KOG1* (resulting in Kog1-S1511L). The *gtr1∆ TOR1-I1954S* double-mutant strain was crossed to a *pib2∆* mutant, resulting in *pib2∆ TOR1-I1954S* double mutants and viable *gtr1∆ pib2∆ TOR1-I1954S* triple mutants, in addition to the single mutants. The *TOR1-I1954S* mutant behaved similar to the hyperactive *TOR1-I1954T* mutant isolated previously as a caffeine-resistant mutant ([@B46]).

The plasmids used in this study were generated using standard cloning procedures. Plasmid pAK018 was generated by PCR amplification of *PIB2* codon sequences from genomic DNA using primers Pib2-F-*Spe*I and Pib2-Stop-*Xho*I. The product was digested with *Spe*I and *Xho*I and ligated into pSM214 ([@B39]) containing an in-frame N-terminal GFP under the methionine-repressible *MET25* promoter. All truncations of Pib2 were generated by PCR amplification of the desired segment from pAK018 using the specified primers. The products were then digested with *Spe*I and *Xho*I and ligated into SM214. pAK023, which contains GFP-Pib2 lacking a functional FYVE domain, was generated by two separate PCRs of the N-terminus and C-terminus. The N-terminus, containing all sequence N-terminal of the FYVE domain (1--1326 base pairs), was digested with *Spe*I and *Xma*I, and the C-terminus, containing all sequence C-terminal of the FYVE domain (1581--1908 base pairs), was digested with *Xma*I and *Xho*I. The two pieces were ligated simultaneously into pSM214.

Stocks of tunicamycin (Sigma-Aldrich, St. Louis, MO), concanamycin C (Santa Cruz Biotechnology, Dallas, TX), and FK506 (Astrellas Pharma, Chu¯o¯, Tokyo, Japan) were dissolved in dimethyl sulfoxide (DMSO) at 1, 1, and 1 mg/ml concentrations, respectively, and stored at −20°C. Fluconazole (Sigma-Aldrich) was dissolved in ethanol to 50 mg/ml and stored at −20°C. Caffeine was freshly dissolved into SC or YPD medium at various concentrations and sterilized by filtration. Propidium iodide (Sigma-Aldrich) was dissolved in phosphate-buffered saline at a concentration of 1 μg/ml; dihydro-DCFDA (Sigma-Aldrich) and FM4-64 (Invitrogen, Carlsbad, CA) were dissolved in DMSO at concentrations of 1 and 1 mg/ml, respectively.

Caffeine-sensitivity assays
---------------------------

*S. cerevisiae* strains were grown overnight to stationary phase in SC medium or SC-leucine medium (to select for plasmids) containing 100--12% methionine, then diluted 500-fold into the same medium containing serial dilutions of caffeine, ranging from 25 to 0.1 mM. After 24 h of incubation at 30°C in flat-bottom 96-well dishes, the optical densities at 650 nm were measured. The concentration of caffeine causing 50% inhibition of growth (IC~50~) was determined by nonlinear regression of the data to the standard four-parameter sigmoid equation, and the IC~50~ determinations from replicate experiments with each mutant strain were averaged.

Cell-staining methods
---------------------

Log-phase *S. cerevisiae* cells growing in SC medium were exposed to tunicamycin (2 μg/ml), fluconazole (25 μg/ml), rapamycin (0.2 μg/ml), caffeine (various concentrations), concanamycin C (3 μM), FK506 (1 μg/ml), or combinations thereof for various lengths of time; pelleted; and stained for 15 min at room temperature in the same medium containing freshly prepared PI (0.25 μg/ml) and/or dihydro-DCFDA (1 μg/ml). Stained cells were imaged using an LSM 510 META confocal microscope (Zeiss) with appropriate filter sets, photographed, and counted manually after appropriate binning. In some experiments, log-phase cells were prestained with FM4-64 (10 μg/ml) for 15 min at 30°C, washed, and incubated for an additional 15 min at 30°C to allow complete endocytosis to the vacuole before addition of stressors and imaging ([@B63]). Most often, 2000 live and dead cells in each culture were counted after PI staining using a BD FACSArray instrument, as described previously ([@B15]; [@B30]). For generating the black curves in [Figure 2B](#F2){ref-type="fig"}, the measured frequencies of PI-stained cells in the cultures were fitted to the standard sigmoid equation (= min + (max − min)/(1 + (MLS/*t*)^slope^); where min and max were pegged at 1 and 100% and median lifespan and slope factor were solved). For generating the gray curves in [Figure 2B](#F2){ref-type="fig"}, the measured frequencies of dihydro-DCFDA--stained cells in the cultures were fitted to a standard sigmoid equation (as above) minus the best-fit sigmoid equation obtained from the PI-stained cells in that culture.

Western blotting
----------------

Cultures were grown to log phase at 30°C in SC medium and adjusted to the same density. Samples were treated with FK506 (1 μg/ml), tunicamycin (2 μg/ml), or rapamycin (0.2 μg/ml) for various lengths of time at 30°C before processing. Processing involved centrifuging 800 μl of cells at 4°C, lysis of cells with 10% ice-cold trichloroacetic acid, extraction of proteins with SDS sample buffer at 37°C, then SDS--PAGE, and Western blotting, as described previously ([@B39]). Blots were probed with anti-hemagglutinin (HA) monoclonal antibodies at 1:10,000 dilution (Covance, Princeton, NJ), anti-phospho S6 (Ser-235/236) monoclonal antibodies at 1:5000 dilution (Cell Signaling, Danvers, MA), anti-RPS6 polyclonal antibodies at 1:5000 dilution (Abcam, Cambridge, United Kingdom), or anti-Pib2 antibodies (kind gift of Chris Burd, Yale University). Protein standards were probed with anti-PGK1 antibodies at 1:10,000 (Abcam).

Computational methods
---------------------

For identification of orthologues of Pib2, standard protein PSI-BLAST searches of nonredundant protein sequences were restricted to fungi (taxid:4751; [@B2]). The hits were collected and subjected to multiple sequence alignment using the CLUSTAL W ([@B60]) with MegAlign software, and segments of strong sequence conservation were identified among the sequences (labeled A--E, FYVE, and T in [Figure 1](#F1){ref-type="fig"}). True orthologues of Pib2 could not be identified readily in metazoa because of strong conservation of FYVE domains in several different protein families. We therefore utilized the SMART database ([@B47]) to identify all 27 human proteins bearing FYVE domains and to focus attention on those proteins for which the FYVE domain was located near the C-terminus and a C-terminal sequence motif was conserved in orthologues from other species. Only LAPF/phafin1 and its orthologues contained a tail motif separated from the FYVE domain by a poorly conserved spacer sequence, similar to Pib2 and its orthologues. Sequence logos that summarize the degree of conservation at each amino acid position were generated from multiple sequence alignments of Pib2 and LAPF/phafin1 orthologues using WebLogo ([@B14]). Hierarchical clustering of chemical and genetic interaction profiles was performed using Cluster 3.0 using the correlation (uncentered) setting ([@B17]). After clustering was complete, the tables of genetic and chemical interactions were reordered, and new tables containing the Pearson correlation coefficients between each gene and every other gene were generated. Portions of these tables are shown in [Figure 3, A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}, and the complete tables are available upon request.

While studying the clusters containing *pib2∆* mutants, we noticed that an *ecm8∆* mutant coclustered with *pib2∆* and other TORC1-deficient strains when it was used as a query strain but not as an array strain. An independently generated *ecm8∆* mutant strain behaved like wild-type parents in similar assays (unpublished data). Because the *ECM8* gene is located adjacent to the *EGO3* gene, we tested whether the *ecm8∆* query strain harbors an unexpected *ego3* mutation by performing complementation tests. The *ecm8∆* array strain failed to complement the *ego3∆* query strain in assays of cell death and caffeine hypersensitivity, and therefore the *ECM8* gene was relabeled as *EGO3\** in [Figure 3](#F3){ref-type="fig"}.

This article was published online ahead of print in MBoC in Press (<http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E15-08-0581>) on October 28, 2015.

The authors are particularly indebted to Stephen Helliwell (Novartis), who shared unpublished data on Pib2 localization and *pib2∆* phenotypes; Chris Burd (Yale University), who shared unpublished results and provided anti-Pib2 polyclonal antibodies; and Michael Costanzo and Brenda Andrews (University of Toronto), who shared unpublished SGA data that supplemented [Figure 3](#F3){ref-type="fig"}. Robbie Loewith (University of Geneva), Claudio De Virgilio (University of Fribourg), and Chris Kaiser (Massachusetts Institute of Technology) supplied helpful plasmids. Richard Bennett (Brown University) supplied *C. albicans* strains. We thank Hyemin Kim, Nathan Snyder, and other members of the Cunningham lab for their advice on the research. This research was generously supported by grants from the National Institutes of Health (T32-GM007231 to the CMDB graduate training program at Johns Hopkins University; R21-AI115016 to K.W.C.).

Cmk2

:   Ca^2+^/calmodulin-dependent protein kinase

DCFDA

:   2′,7′ --dichlorofluorescin diacetate

DMSO

:   dimethyl sulfoxide

DTT

:   dithiothreitol

ER

:   endoplasmic reticulum

GFP

:   green fluorescent protein

HA

:   hemagglutinin

LMP

:   lysosomal membrane permeabilization

PH

:   pleckstrin homology

PI(3)P

:   phosphatidylinositol 3-phosphate

PI(3,5)P2

:   phosphatidylinositol 3,5-bisphosphate

Rps6

:   ribosomal protein S6

SC

:   synthetic complete

UPR

:   unfolded protein response

YPD

:   yeast--peptone--dextrose.
